报价延迟最少15分钟:2026/06/01 18:02 EDT
盘后时段
|
||||
|
14.128 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
14.26
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.56/-1.79
|
|
企业价值
3.09B
|
| 资产负债 |
|
每股账面净值
2.95
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
15.36M
|
|
每股收益
0.12
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others. |
